IIFL View
Go
  • Indraprastha Gas

    We expect the company to report total volume growth of ~14% CAGR over FY18-20E aided by (a) 19% CAGR volume growth for PNG users and (b) 11% CAGR volume growth for CNG users. The company is also benefiting from conversion of vehicles to CNG on the back ...

    Buy Reco. Price: 285.00

  • Tata Global

    Company is focusing on (a) turning around/selling loss-making entities, (b) cost rationalisation, and (c) thrust on new growth opportunities. Factoring in the muted performance so far in 9MFY19, we estimate revenue CAGR of 7.5% over FY18-20E (due to decline...

    Buy Reco. Price: 183.65

  • Cera Sanitary.

    Demand for branded sanitaryware products is rising on the back of rise in spending on home improvement. Cera has seen an increase in its capacity utilization. Sanitaryware segment is operating at ~98%, faucet at ~65% and tiles at ~75-80% capacity utiliz...

    Buy Reco. Price: 2,306.00

  • Page Industries

    Page Industries (Page), is set to expand its capacity in KIADB industrial area (Bangalore). We expect revenue CAGR of ~18% over FY18-20E due to (a) expanded distribution network of company’s brand ‘Jockey’, (b) shift towards organised sect...

    Reduce Reco. Price: 23,600.00

  • Biocon

    Biocon’s early entry in the biosimilars business is a long term positive for the company. Biocon-Mylan has recently received an approval for Trastuzumab and Pegfilgrastim in US and we expect approval to 2-3 more biosimilars in 2019/2020 across US and ...

    Buy Reco. Price: 643.00

  • Alembic Pharma

    Alembic (APL) is planning to launch 20-25 products in India. Company expects to launch derma products in FY20E and injectable products from FY21E in the US market. We expect CAGR of 12%/11% in revenue/PAT over FY19E-21E. Margins would be flat over FY19E and...

    Buy Reco. Price: 559.00

  • Aurobindo Pharma

    Aurobindo has acquired the generic drug and branded dermatology portfolio from Sandoz at 6.2x EV/EBITDA. The deal is value accretive and has added 300 ANDAs in Aurobindo’s portfolio as well as three manufacturing facilities. We are positive on Aurobin...

    Buy Reco. Price: 761.00

  • Lupin

    Lupin is facing high competition and pricing pressure in key products such as gGlumetza and gFortamet. While successful audits by Health Canada (Pithampur-II) and UK-MHRA (Goa) have eased some regulatory pressure, USFDA clearance to the Goa/Pithampur-II pla...

    Sell Reco. Price: 830.00

  • Bharti Infra.

    Bharti Infratel Ltd (BIL) to report revenue growth of 2.2% CAGR over FY18-20E due to rise in tower count owing to coverage expansion. The stock also offers a dividend yield of ~5%. We expect PAT de-growth of 7.7% CAGR over FY18-20E due to lower margins as s...

    Sell Reco. Price: 319.00

  • Vardhman Textile

    Vardhman Textiles (VTL) is planning capex of Rs1,500cr over the next 2-3 years towards expansion in Satlapur and Budhni in Madhya Pradesh, in addition to modernisation of other units. Capex would be split equally between yarn and fabric production facil...

    Buy Reco. Price: 1,050.00